Loteprednol etabonate: Completed Phase III testing

Pharmos Corp. (PARS), New York Product: Loteprednol etabonate, an ophthalmic steroid Indication: Giant papillary conjunctivitis Status: Completed Phase III testing; with completion of the other three...